FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot ...
2 days ago · Novavax Inc. (NASDAQ:NVAX) stock is trading lower on Wednesday. The FDA has placed a clinical hold on Novavax’s Investigational New Drug (IND) application for its COVID-19-influenza combination ...
Novavax stock plunges as FDA puts clinical hold on COVID-flu ...
2 days ago · Shares of Novavax (NASDAQ:NVAX) fell roughly 30% Wednesday morning after the U.S. FDA put a clinical hold on the new drug application of its COVID-19 and influenza combination vaccine and ...
Novavax (NVAX) Advances While Market Declines: Some ... - Nasdaq
1 day ago · In the latest market close, Novavax (NVAX) reached $10.35, with a +1.97% movement compared to the previous day. The stock outperformed the S&P 500, which registered a daily loss of 0.02%. On the ...
Novavax, Inc. (NVAX) Latest Stock News & Headlines - Yahoo ...
Get the latest Novavax, Inc. (NVAX) stock news and headlines to help you in your trading and investing decisions.
Novavax, Inc. (NVAX) Latest Press Releases & Corporate News ...
Get the latest Novavax, Inc. (NVAX) stock news and headlines to help you in your trading and investing decisions.
NVAX Stock Price | Novavax Inc. Stock Quote (U.S.: Nasdaq ...
2 days ago · NVAX | Complete Novavax Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Novavax shares soar on license deal with Sanofi at lofty ...
May 10 (Reuters) - Novavax (NVAX.O) on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi (SASY.PA) for its COVID-19 vaccine in exchange for a stake that valued...
Novavax Presents Data on Updated COVID-19 Vaccine and ...
Apr 1, 2024 · Novavax will showcase data from its updated COVID-19 vaccine and provide an overview of its influenza and COVID-19-Influenza Combination vaccine candidates at the World Vaccine Congress 2024.
Novavax's Updated Protein-based COVID-19 Vaccine Now an ...
Nov 28, 2023 · Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Nuvaxovid™ XBB.1.5 COVID-19 Vaccine (NVX-CoV2601) has been...
US FDA pauses Novavax's trial of combo COVID-flu shot on ...
2 days ago · Show more companies. Oct 16 (Reuters) - The U.S. Food and Drug Administration has put on hold a trial of Novavax's (NVAX.O) COVID-influenza and its standalone flu vaccines after a participant who ...